$35.9 Million is the total value of EMORY UNIVERSITY's 20 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 23.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VWO | Sell | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $10,188,000 | -76.5% | 307,890 | -70.9% | 28.38% | -51.5% |
| VSAT | Buy | VIASAT INC | $1,627,000 | +12.1% | 25,305 | +5.1% | 4.53% | +130.8% |
| INCY | Buy | INCYTE CORP | $1,576,000 | +7.8% | 14,287 | +1.8% | 4.39% | +121.9% |
| ACGL | Sell | ARCH CAP GROUP LTDord | $1,510,000 | -4.4% | 20,551 | -12.9% | 4.21% | +96.9% |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $1,475,000 | – | 129,415 | +100.0% | 4.11% | – |
| LVNTA | Buy | LIBERTY INTERACTIVE CORP | $1,470,000 | +7.4% | 36,425 | +4.5% | 4.09% | +121.1% |
| LPLA | Sell | LPL FINL HLDGS INC | $1,401,000 | -16.8% | 35,231 | -2.7% | 3.90% | +71.4% |
| ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $1,382,000 | -9.2% | 17,064 | -0.3% | 3.85% | +86.9% |
| LMCK | Buy | LIBERTY MEDIA CORP DELAWARE | $1,374,000 | -3.7% | 39,882 | +0.3% | 3.83% | +98.2% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $1,373,000 | -16.8% | 41,505 | +5.3% | 3.82% | +71.2% |
| SGEN | Sell | SEATTLE GENETICS INC | $1,330,000 | -27.0% | 34,504 | -8.3% | 3.70% | +50.3% |
| ANAC | Sell | ANACOR PHARMACEUTICALS INC | $1,306,000 | -29.9% | 11,096 | -53.9% | 3.64% | +44.4% |
| WBC | Buy | WABCO HLDGS INC | $1,304,000 | -9.3% | 12,439 | +7.1% | 3.63% | +86.8% |
| GHDX | Buy | GENOMIC HEALTH INC | $1,287,000 | -15.8% | 60,828 | +10.7% | 3.58% | +73.4% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $1,267,000 | -24.4% | 8,101 | -12.7% | 3.53% | +55.5% |
| NVTA | Buy | INVITAE CORP | $1,254,000 | -19.6% | 173,743 | +65.7% | 3.49% | +65.5% |
| KMI | Buy | KINDER MORGAN INC DEL | $1,220,000 | -9.9% | 44,064 | +24.9% | 3.40% | +85.5% |
| TV | New | GRUPO TELEVISA SAspon adr rep ord | $1,207,000 | – | 46,388 | +100.0% | 3.36% | – |
| AR | Buy | ANTERO RES CORP | $1,179,000 | -2.5% | 55,717 | +58.3% | 3.28% | +100.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $1,175,000 | -29.4% | 11,155 | -8.3% | 3.27% | +45.4% |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -23,333 | -100.0% | -1.90% | – |
| QRTEA | Exit | LIBERTY INTERACTIVE CORP | $0 | – | -52,924 | -100.0% | -1.99% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -56,383 | -100.0% | -2.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-02-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.